Stuart A. Arbuckle
2018
Compensation breakdown
Non-Equity Incentive Plan | $824,175 |
---|---|
Option Awards | $1,136,785 |
Salary | $721,923 |
Stock Awards | $2,625,244 |
Other | $38,965 |
Total | $5,347,092 |
Arbuckle received $2.6M in stock awards, accounting for 49% of the total pay in 2018.
Arbuckle also received $824.2K in non-equity incentive plan, $1.1M in option awards, $721.9K in salary and $39K in other compensation.
Rankings
In 2018, Stuart A. Arbuckle's compensation ranked 1,836th out of 14,244 executives tracked by ExecPay. In other words, Arbuckle earned more than 87.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,836 | 87th |
Manufacturing | 652 | 89th |
Chemicals And Allied Products | 215 | 90th |
Drugs | 168 | 91st |
Pharmaceutical Preparations | 126 | 91st |
Pay ratio
Stuart A. Arbuckle's Pay | $5,347,092 |
---|---|
Median Employee's Pay | $232,178 |
Pay Ratio | 23to 1 |
In 2018, the annual total compensation of Stuart A. Arbuckle was $5,347,092.
The annual total compensation of the median employee at Vertex Pharmaceuticals was $232,178.
The ratio of Stuart A. Arbuckle's pay to the pay of median employee was therefore 23 to one.
Arbuckle's colleagues
We found six more compensation records of executives who worked with Stuart A. Arbuckle at Vertex Pharmaceuticals in 2018.
2018
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2018
Jeffrey Chodakewitz
Vertex Pharmaceuticals
Chief Medical Officer
2018
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Regulatory Officer
2018
Michael Parini
Vertex Pharmaceuticals
EVP & Chief Legal and Administrative Officer
2018
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2018
Thomas Graney
Vertex Pharmaceuticals